Medicare Enrolled

Dr. Hunaid Hasan, MD

Neurology · Lapeer, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
237 DAVIS LAKE RD STE B, Lapeer, MI 48446
8106679132
In practice since 2014 (12 years)
NPI: 1578983581 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hasan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hasan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hasan

Dr. Hunaid Hasan is a neurology specialist in Lapeer, MI, with 12 years of NPI registration. Based on federal Medicare data, Dr. Hasan performed 4,099 Medicare services across 2,122 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hasan received a total of $16,038 from 61 pharmaceutical and/or device companies across 677 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hasan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 6% volume in MI $16,038 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,099
Medicare services
Top 6% in MI for neurology
2,122
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~342 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
664 $62 $180
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
558 $84 $200
Injection of anesthetic agent and/or steroid into rib nerve 445 $66 $300
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
426 $61 $194
Lower back and sciatic nerve injection
An injection of an anesthetic and/or steroid medication into the lower back and sciatic nerve. This procedure delivers medication directly to the nerve site.
355 $170 $499
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
259 $38 $198
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
238 $70 $201
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
202 $92 $150
Injection of anesthetic or steroid into upper neck and back of head nerve
An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head.
201 $48 $400
Rib nerve block injection
An injection of anesthetic and/or steroid medication into multiple rib nerves to block pain signals in the chest wall.
153 $35 $327
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
151 $42 $162
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
147 $134 $300
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
120 $156 $400
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
89 $101 $300
Facial nerve injection with anesthetic and/or steroid
An injection of an anesthetic agent and/or steroid into the facial nerve. This procedure delivers medication directly to the nerve.
26 $119 $365
VEEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
24 $152 $350
EEG monitoring, 2-12 hours with review
This procedure records brain wave activity for 2 to 12 hours. A healthcare professional reviews the data and provides a report.
15 $72 $300
EEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
15 $113 $250
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
11 $70 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,038
Total received (2018-2024)
Avg $2,291/year across 7 years
Top 18% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
677
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,001 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$38 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,292
2023
$3,039
2022
$2,802
2021
$2,654
2020
$232
2019
$3,670
2018
$350

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$474
Biogen, Inc.
$342
PFIZER INC.
$281
UCB, Inc.
$211
Novartis Pharmaceuticals Corporation
$186
Eisai Inc.
$175
Genentech USA, Inc.
$163
Lilly USA, LLC
$134
Neurocrine Biosciences, Inc.
$106
Neurelis, Inc.
$105
Sumitomo Pharma America, Inc.
$102
SK Life Science, Inc.
$100
Teva Pharmaceuticals USA, Inc.
$98
Kyowa Kirin, Inc.
$91
CATALYST PHARMACEUTICALS, INC.
$89
Alexion Pharmaceuticals, Inc.
$87
ACADIA Pharmaceuticals Inc
$74
ARGENX US, INC.
$69
Lundbeck LLC
$64
JAZZ PHARMACEUTICALS INC.
$62
Celgene Corporation
$62
Otsuka America Pharmaceutical, Inc.
$54
Amneal Pharmaceuticals LLC
$25
Chiesi USA, Inc.
$23
MDD US Operations, LLC
$23
Supernus Pharmaceuticals, Inc.
$22
CSL Behring
$19
Aucta Pharmaceuticals, Inc.
$18
Medtronic, Inc.
$17
MITSUBISHI TANABE PHARMA AMERICA, INC.
$17
Top 3 companies account for 33.3% of 2024 payments
All-time payments by company (2018-2024) ›
NeuroPace, Inc.
$2,419
UCB, Inc.
$1,107
Biogen, Inc.
$1,077
ABBVIE INC.
$931
LivaNova USA, Inc.
$735
SK Life Science, Inc.
$646
Neurocrine Biosciences, Inc.
$625
Novartis Pharmaceuticals Corporation
$570
Genentech USA, Inc.
$514
PFIZER INC.
$481
Teva Pharmaceuticals USA, Inc.
$468
Celgene Corporation
$464
Lilly USA, LLC
$373
ACADIA Pharmaceuticals Inc
$357
US WorldMeds, LLC
$331
Eisai Inc.
$291
Neurelis, Inc.
$275
GENZYME CORPORATION
$261
JAZZ PHARMACEUTICALS INC.
$242
Sumitomo Pharma America, Inc.
$232
Kyowa Kirin, Inc.
$218
Amgen Inc.
$213
Medtronic, Inc.
$213
ARGENX US, INC.
$191
Alexion Pharmaceuticals, Inc.
$183
Biohaven Pharmaceuticals, Inc.
$170
Acorda Therapeutics, Inc
$160
Allergan Inc.
$137
CATALYST PHARMACEUTICALS, INC.
$133
AbbVie Inc.
$125
Horizon Therapeutics plc
$122
Sunovion Pharmaceuticals Inc.
$119
Zogenix Inc.
$119
Biohaven Pharmaceutical Holding Company Ltd.
$117
Lundbeck LLC
$114
MDD US Operations, LLC
$113
MITSUBISHI TANABE PHARMA AMERICA, INC.
$109
Supernus Pharmaceuticals, Inc.
$104
Janssen Pharmaceuticals, Inc
$100
EMD Serono, Inc.
$98
Otsuka America Pharmaceutical, Inc.
$93
Alnylam Pharmaceuticals Inc.
$92
Greenwich Biosciences, Inc.
$64
EISAI INC.
$63
Avion Pharmaceuticals
$51
HARMONY BIOSCIENCES LLC
$43
Corium, LLC
$42
Amneal Pharmaceuticals LLC
$42
CSL Behring
$37
Harmony Biosciences LLC
$34
GE HealthCare
$28
Allergan, Inc.
$28
Avanir Pharmaceuticals, Inc.
$27
Catalyst Pharmaceuticals, Inc.
$27
Chiesi USA, Inc.
$23
Aucta Pharmaceuticals, Inc.
$18
Grifols USA, LLC
$17
GE HEALTHCARE
$16
E.R. Squibb & Sons, L.L.C.
$14
BioDelivery Sciences International, Inc.
$12
AstraZeneca Pharmaceuticals LP
$12
Top 3 companies account for 28.7% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ACTIVOS 10 BONE CEMENT · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · ASCENDA · AUBAGIO · AUSTEDO · AVONEX · Activase · Adlarity · Aimovig · Apokyn · Austedo XR · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · CLEVIPREX · COMIRNATY · CREXONT · DUOPA · Dhivy · ELIQUIS · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GIVLAARI · Gamunex-C · Hizentra · INBRIJA · INGREZZA · INTELLIS · KESIMPTA · KISUNLA · KYNMOBI · Leqembi · MAYZENT · MYOBLOC · Motpoly XR · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · ONGENTYS · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ongentys · PAXLOVID · PLEGRIDY · Ponvory · QULIPTA · Qelbree · RADICAVA · REXULTI · RNS System · RYTARY · SOLIRIS · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Lapeer?
Compare neurologists in the Lapeer area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
14
Per 100K population
15.8
County median income
$76,228
Nearest hospital
MCLAREN LAPEER REGION
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hasan is a clinical cardiology specialist, with above-average Medicare volume (top 6% in MI), with low-engagement industry engagement in the top 18% of MI peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hasan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Hasan performed 664 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hasan receive payments from pharmaceutical companies?
Yes. Dr. Hasan received a total of $16,038 from 61 companies across 677 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hasan's costs compare to other neurologists in Lapeer?
Dr. Hasan's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hasan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →